OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

SMA-miRs (miR-181a-5p, -324-5p, and -451a) are overexpressed in spinal muscular atrophy skeletal muscle and serum samples
Emanuela Abiusi, Paola Infante, Cinzia Cagnoli, et al.
eLife (2021) Vol. 10
Open Access | Times Cited: 23

Showing 23 citing articles:

Experience of a 2-year spinal muscular atrophy NBS pilot study in Italy: towards specific guidelines and standard operating procedures for the molecular diagnosis
Emanuela Abiusi, Alessandro Vaisfeld, Stefania Fiori, et al.
Journal of Medical Genetics (2022) Vol. 60, Iss. 7, pp. 697-705
Closed Access | Times Cited: 29

Molecular Biomarkers for the Diagnosis, Prognosis, and Pharmacodynamics of Spinal Muscular Atrophy
Marija Babić, Maria Banović, Ivana Berečić, et al.
Journal of Clinical Medicine (2023) Vol. 12, Iss. 15, pp. 5060-5060
Open Access | Times Cited: 13

MiR34 contributes to spinal muscular atrophy and AAV9-mediated delivery of MiR34a ameliorates the motor deficits in SMA mice
Tai‐Heng Chen, Shih-Hsin Chang, Yu-Fu Wu, et al.
Molecular Therapy — Nucleic Acids (2023) Vol. 32, pp. 144-160
Open Access | Times Cited: 11

Whole-transcriptome sequencing in neural and non-neural tissues of a mouse model identifies miR-34a as a key regulator in SMA pathogenesis
Liucheng Wu, Junjie Sun, Liping Wang, et al.
Molecular Therapy — Nucleic Acids (2025) Vol. 36, Iss. 2, pp. 102490-102490
Open Access

Treating neuromuscular diseases: unveiling gene therapy breakthroughs and pioneering future applications
Yu‐Fu Wu, Jun‐An Chen, Yuh‐Jyh Jong
Journal of Biomedical Science (2025) Vol. 32, Iss. 1
Open Access

Excess PrPC inhibits muscle cell differentiation via miRNA-enhanced liquid–liquid phase separation implicated in myopathy
Jing Tao, Yanping Zeng, Bin Dai, et al.
Nature Communications (2023) Vol. 14, Iss. 1
Open Access | Times Cited: 9

Role of circulating biomarkers in spinal muscular atrophy: insights from a new treatment era
Giorgia Querin, M. Gómez García de la Banda, Piera Smeriglio
Frontiers in Neurology (2023) Vol. 14
Open Access | Times Cited: 8

Insights into spinal muscular atrophy from molecular biomarkers
Xiaodong Xing, Xinzhu Liu, Xiandeng Li, et al.
Neural Regeneration Research (2024) Vol. 20, Iss. 7, pp. 1849-1863
Open Access | Times Cited: 3

270th ENMC International Workshop: Consensus for SMN2 genetic analysis in SMA patients 10–12 March, 2023, Hoofddorp, the Netherlands
Emanuela Abiusi, Mar Costa‐Roger, Enrico Bertini, et al.
Neuromuscular Disorders (2023) Vol. 34, pp. 114-122
Open Access | Times Cited: 6

MicroRNA cargo of extracellular vesicles released by skeletal muscle fibro-adipogenic progenitor cells is significantly altered with disuse atrophy and IL-1β deficiency
Emily Parker, Bharati Mendhe, Ling Ruan, et al.
Physiological Genomics (2022) Vol. 54, Iss. 8, pp. 296-304
Open Access | Times Cited: 9

ALS iPSC-derived microglia and motor neurons respond to astrocyte-targeted IL-10 and CCL2 modulation
Reilly L. Allison, Allison D. Ebert
Human Molecular Genetics (2023) Vol. 33, Iss. 6, pp. 530-542
Open Access | Times Cited: 4

A review on the role of miRNA-324 in various diseases
Sepideh Kadkhoda, Bashdar Mahmud Hussen, Solat Eslami, et al.
Frontiers in Genetics (2022) Vol. 13
Open Access | Times Cited: 7

MicroRNA‑mediated regulation of muscular atrophy: Exploring molecular pathways and therapeutics (Review)
Woohyeong Jung, Uijin Juang, Suhwan Gwon, et al.
Molecular Medicine Reports (2024) Vol. 29, Iss. 6
Open Access | Times Cited: 1

MicroRNAs as Biomarkers in Spinal Muscular Atrophy
Maruša Barbo, Damjan Glavač, Gregor Jezernik, et al.
Biomedicines (2024) Vol. 12, Iss. 11, pp. 2428-2428
Open Access | Times Cited: 1

The Relevance of Spinal Muscular Atrophy Biomarkers in the Treatment Era
Marianna Maretina, V. I. Koroleva, Л. М. Щугарева, et al.
Biomedicines (2024) Vol. 12, Iss. 11, pp. 2486-2486
Open Access | Times Cited: 1

IL-1Ra and CCL5, but not IL-10, are promising targets for treating SMA astrocyte-driven pathology
Reilly L. Allison, Mya Suneja, Megan LaCroix, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2023)
Open Access | Times Cited: 2

The role of microRNAs in muscle wasting and recovery during critical illness: a systematic review
María Borja-Gonzalez, Sarah M. Coyne, Sarah Fagan, et al.
JCSM Rapid Communications (2023) Vol. 6, Iss. 2, pp. 68-80
Open Access | Times Cited: 1

SMA Type II Skeletal Muscle Treated with Nusinersen shows SMN Restoration but Mitochondrial Deficiency.
Fiorella C. Grandi, Stéphanie Astord, Elèna Gidaja, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2024)
Open Access

Characterization of SMA Type II Skeletal Muscle from Treated Patients shows Mitochondrial Deficiency and Denervation
Fiorella C. Grandi, Stéphanie Astord, Sonia Pezet, et al.
JCI Insight (2024) Vol. 9, Iss. 20
Open Access

An early Transcriptomic Investigation in Adult Patients with Spinal Muscular Atrophy Under Treatment with Nusinersen
Maria Liguori, Annalisa Bianco, Alessandro Introna, et al.
Journal of Molecular Neuroscience (2024) Vol. 74, Iss. 4
Open Access

High Expression of SMN circ4-2b-3 in SMA I Children Treated with Nusinersen is Associated with Improved Motor Outcomes
Marika Guerra, Alberto Marini, Vittoria Pagliarini, et al.
Molecular Neurobiology (2024)
Closed Access

ALS iPSC-derived microglia and motor neurons respond to astrocyte-targeted IL-10 and CCL2 modulation
Reilly L. Allison, Allison D. Ebert
bioRxiv (Cold Spring Harbor Laboratory) (2023)
Open Access

Page 1

Scroll to top